MalariaWorld Journal is the first truly Open Access, peer reviewed, scientific journal with an exclusive focus on malaria – where you don’t pay to publish and you don’t pay to read.
P.O. Box 18, 6669 ZG Dodewaard, The Netherlands
Location: Kalkestraat 20, Dodewaard, The Netherlands
Nijmegen Centre for Molecular Life Sciences, Medical Microbiology
Geert Grooteplein 26-28, Nijmegen 6525 GA, Netherlands
For all questions about MWJ and for submission of articles, please contact us at email@example.com
Members of the MWJ team:
Editor-in-Chief: Dr. Teun Bousema (Radboud University Nijmegen, the Netherlands). For a list of publications of Teun Bousema click "Teun Bousema Publications
Editor: Dr. Bart Knols (In2Care, Wageningen, the Netherlands). For a list of publications of Bart Knols click "Bart Knols Publications
Copy editor: Monika Bongers (Netherlands)
Director Dutch Malaria Foundation: Ingeborg van Schayk (Netherlands)
Editorial process, peer review and decision-making
Submitted manuscripts will first be examined for completeness, adherence to article preparation guidelines, and overall scientific merit before being sent out for review. Peer review is designed to ensure that the research published is 'good science'. We aim to send the manuscripts for review within 3 working days after receiving the manuscript. Corresponding authors are notified by email if their submission is not accepted at this stage.
Submitted manuscripts are reviewed by two or more experts. Peer reviewers have six possible options: accept without revisions; accept after optional revisions; accept after essential revisions; decision to be made after compulsary revisions have been applied; reject because scientifically unsound; reject because not suitable for publication at all. External reviewers are selected on the basis of affinity with the topic of the manuscript, absence of conflict of interest, and general expertise. Following receipt of the review, the authors are requested to respond in full to the queries of the reviewers, in writing, and highlight changes clearly when submitting their revision.
Following external review, the editor-in-chief of MWJ makes a decision on how to proceed with the manuscript. Authors will be notified by email regarding the outcome of the review. Decisions by the editor-in-chief are binding and final.
Accepted manuscripts will proceed to the typesetting stage. Authors will receive proofs of the final version of the article prior to publication and be allowed to propose minor changes. Publication of the final version of the article is completed upon receiving the final acceptance by the corresponding author.
Ownership of copyright
The MalariaWorld Journal (MWJ) applies the Creative Commons Attribution License (CC-BY)
to all works we publish (read the full license legal code
). Under this license, authors retain ownership of the copyright for their content, but allow anyone to download, reuse, reprint, modify, distribute, and/or copy the content as long as the original authors and source are cited. No permission is required from the authors or the publishers.
Appropriate attribution can be provided by simply citing the original article (e.g., Bate, R., et al., 2012. The AMFm and medicine diversion: Good intent enabling corrupt practices. MalariaWorld Journal, 3: 2).
For any reuse or redistribution of a work, users must also make clear the license terms under which the work was published.
This broad license was developed to facilitate free access to, and unrestricted reuse of, original works of all types. Applying this standard license to your own work will ensure that it is freely and openly available in perpetuity.
MWJ is an online journal that is published on the online MalariaWorld platform (www.malariaworld.org
). MalariaWorld is the world’s scientific and social network for malaria professionals. It has 8500+ members from 140 countries.
The Dutch Malaria Foundation welcomes target group relevant advertisements on MalariaWorld.
The Dutch Malaria Foundation reserves the right to decline or remove any type of advertising that is considered inappropriate to MWJ, MalariaWorld and its users.
All editorial decisions are independent from advertisers and sponsors. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors.
Advertisements must be verifiable and may not be misleading. Advertisements that are offensive or relate to content of a personal, sexual, racial, ethnic or religious nature will not be accepted.
Conflict of interest
In our definition, a conflict of interest exists when professional judgment concerning a primary interest (such as validity of research) may be influenced by a secondary interest (such as financial gain). Perceptions of conflict of interest are as important as actual conflicts of interest. Financial relationships, personal relationships or rivalries, academic competition, and intellectual beliefs can all form conflicts of interest for authors, reviewers and editors and have to be declared prior to submission of manuscripts or when accepting a role as reviewer or editor.
Human and animal rights
For all research involving human subjects, informed consent to participate in the study should be obtained from participants or their caretakers.
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki
and must have been approved by an appropriate ethics committee.
Experimental research on animals must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration
outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.
The Editors may reject a manuscript if there is suspicion that research has not taken place within an appropriate ethical framework. Reviewers and editors will also need to declare any conflict of interest and may be excluded from the review process.
Access for journalists
MWJ articles will be published electronically immediately upon acceptance. Journalists, like everyone else, will have access to the published material immediately upon acceptance.
The International Committee of Medical Journal Editors’ uniform requirements for manuscripts
Authorship and contributions
We ask corresponding authors to clarify the role of each listed author on the manuscript, although we do not publish this in the final article. To qualify as an author on a publication in MWJ, authors have to fulfil the 4 criteria defined by ICMJE: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; (2) Drafting the work or revising it critically for important intellectual content; (3) Final approval of the version to be published; and (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors who do not fulfill one or more of these criteria should be listed in the acknowledgements.
Transparency and conflict of interest
All conflict of interests need to be declared prior to submitting a manuscript or accepting a role as reviewer or editor. See above “Conflict of interest”.
There a no fees involved for manuscript processing and/or publishing materials.
What MWJ promises:
- Confidentiality and transparency. Manuscripts submitted to MWJ are privileged communications that are authors’ private, confidential property, and authors will not be harmed by premature disclosure of any or all of a manuscript’s details. Editors will not share information about manuscripts, including whether they have been received and are under review, their content and status in the review process, criticism by reviewers, and their ultimate fate, to anyone other than the authors and reviewers.
Editors also make clear that reviewers should keep manuscripts, associated material, and the information they contain strictly confidential and report any (perceived) conflicts of interest before accepting or rejecting a task as editor for a given manuscript.
- Timely review. MWJ aims to provide prompt feedback to authors that can help them to improve their manuscript for re-submission to MWJ or a different journal. We give our reviewers 4 weeks for initial review and reviewers receive reminders once this deadline has passed.
- Thorough review. The MWJ reviewing process aims to ensure a fair hearing for a manuscript among members of the scientific community before editors take a decision to accept or reject a manuscript. We select expert reviewers from the large academic network of MalariaWorld, an online community of malaria researchers. Editorial decisions are based on peer review, the relevance of a manuscript to MWJ and on the manuscript’s originality, quality, and contribution to evidence about important questions. Those decisions are not be influenced by commercial interests, personal relationships or agendas, or findings that are negative or that credibly challenge accepted wisdom.
- Protection of research participants. Many of the manuscripts published in MWJ are based on studies involving human participants or, less frequently, animal studies. When reporting research involving human data, authors have to indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), and whether research was conducted in accordance with the Helsinki Declaration.